cipamfylline
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background: Eczema is a very common chronic inflammatory skin condition.
Objectives: To update the National Institute for Health…
The phosphodiesterase (PDE) 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including…
BackgroundNew therapeutic approaches have to be considered in the treatment of irritant contact dermatitis (ICD). Recently…
Gateways to clinical trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Summary Background Therapeutic options to treat atopic dermatitis are limited. Leukocytes from atopic patients have an abnormally…
La presente invention concerne de nouvelles formes polymorphes cristallines, Forme I, II et IV de la Cipamfylline, leurs procedes…
(57) [summary] The present invention relates to a novel crystalline polymorph form a is type I cipamfylline, II and IV type, a…